The North America human vaccines market is expected to reach US$ 24,510.0 Mn in 2027 from US$ 14,566.0 Mn in 2018. The market is estimated to grow with a CAGR of 6.0% from 2019-2027.
The growth of the market is driven by the factors such as compulsion or mandate vaccination and dropping vaccination rates. However, the vaccines market is likely to get impacted due to the low awareness about the benefits of vaccines during the forecast period.
The epidemic of measles in Disneyland in California, US has enforced the dropping of the rates for the vaccination. The instance took place in 2014, the epidemic of the measles has sickened approximately 111 people in California and has also spread to six other states as well as Canada and Mexico. The vaccination has been used safely and effectively for the decades and the rising numbers of the measles has led to more vaccinations. The children are more susceptible to falling prey to the diseases, therefore majority of the parents in US vaccinate their children on schedule.
Additionally, the vaccinations rates are reimbursed by the Medicaid and the reimbursement for Medicaid vaccine administration varies by state however it is as low as US$2 in some states. Also the use of the combination vaccines has been permitted by the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control (CDC). This is a safe and efficacious measure to decrease the number of injections needed to complete the childhood immunization schedule. Hence, the dropping rates of the vaccination rates are likely to raise the market significantly in the forecast period.
US is expected to lead the market in the North American region due to the rapid growth of the biopharmaceutical industry. The industry is experiencing the rapid growth due to technological advancements and increasing flexibility and low operational cost are also adding to the growth of the market. In addition, in the country the government has mandate the immunization and vaccination for preventable diseases. The growth of the market is also defined by the rising prevalence of the infectious and parasitic diseases as the diseases are alarming the need of the vaccination in the country. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North American region during the forecast period.
Rest of North America Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA VACCINES- MARKET SEGMENTATION
By Technology
- Recombinant vaccines
- Conjugate Vaccines
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
NORTH AMERICA VACCINES - MARKET SEGMENTATION
By Disease Indication
- DTP (diphtheria, tetanus, and pertussis)
- Influenza
- Hepatitis
- Other Diseases
NORTH AMERICA VACCINES - MARKET SEGMENTATION
By Rout of Administration
- Oral
- Injectable
- Other
NORTH AMERICA VACCINES - MARKET SEGMENTATION
By Patient Type
- Adults
- Pediatric
By Country
- U.S
- Canada
- Mexico
Companies Mentioned
- PFIZER INC
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Sanofi
- Johnson & Johnson Services, Inc
- Panacea Biotec Limited
- Astellas Pharma Inc.
- NOVAVAX, INC.
- VBI Vaccines Inc
- Bavarian Nordic.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Disease Indication, Route of Administration, Patient Type, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. North America Vaccines Market - Key takeaways
PART 3. North America Vaccines market - market landscape
3.1 overview
3.2 market segmentation
3.2.1 North America Vaccines Market - By Technology
3.2.2 North America Market - By Disease Indication
3.2.3 North America Vaccines Market - By Route of Administration
3.2.4 North America Vaccines Market - By Patient Type
3.2.5 North America Vaccines Market - By Country
3.3 PEST Analysis
PART 4. North America VAccines market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Compulsion or Mandate Vaccination
4.1.2 Dropping Vaccination Rates
4.2 Key Market Restraints
4.2.1 Low Awareness About the Benefits of Vaccines
4.3 Key Market Opportunities
4.3.1 Rising Numbers of Diseases
4.4 future Trends
4.4.1 Advances in Vaccine Technology
4.5 Impact analysis
PART 5. VAccines market - North America Analysis
5.1 North America Vaccines market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
PART 6. North America vaccines market Analysis - By TEchnology
6.1 Overview
6.2 NORTH AMERICA vaccines MARKET, BY Type, 2018 & 2027 (%)
6.3 North America Vaccines market Revenue And Forecasts to 2027, By echnology (US$ Mn)
6.4 Norh America Recombinant Vaccines Market
6.4.1 Overview
6.4.2 North America Recombinant Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.5 North America Conjugate Vaccines Market
6.5.1 Overview
6.5.2 North America Conjugate Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.6 North America Live Attenuated Vaccines Market
6.6.1 Overview
6.6.2 North America Live Attenuated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.7 North America Inactivated Vaccines Market
6.7.1 Overview
6.7.2 North America Inactivated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.8 North America toxoid Vaccines Market
6.8.1 Overview
6.8.2 North America Toxoid Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
PART 7. North America Vaccines market Analysis - By Disease Indication
7.1 Overview
7.2 NORTH AMERICA vaccines MARKET, BY disease indication, 2018 & 2027 (%)
7.3 North America Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
7.4 North America DTP (diphtheria, tetanus, and pertussis) Market
7.4.1 Overview
7.4.2 North America DTP (Diphtheria, Tetanus, And Pertussis) Market Revenue and Forecast to 2027 (US$ Mn)
7.5 North AMerica Influenza Market
7.5.1 Overview
7.5.2 North America Influenza Market Revenue and Forecast to 2027 (US$ Mn)
7.6 North America Hepatitis Market
7.6.1 Overview
7.6.2 North America Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)
7.7 North America Other Diseases Market
7.7.1 Overview
7.7.2 North America Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)
PART 8. North America Vaccines market Analysis - By Route of administration
8.1 Overview
8.2 NORTH AMERICA Vaccines MARKET, BY route of administration, 2018 & 2027 (%)
8.3 North America Vaccines market Revenue And Forecasts to 2027, By route of administration (US$ Mn)
8.4 North America Oral Market
8.4.1 Overview
8.4.2 North America Oral Market Revenue and Forecast to 2027 (US$ Mn)
8.5 North AMerica Injectable Market
8.5.1 Overview
8.5.2 North America Injectable Market Revenue and Forecast to 2027 (US$ Mn)
8.6 North America Other Routes of Administration Market
8.6.1 Overview
8.6.2 North America Other Routes of Administration Market Revenue and Forecast to 2027 (US$ Mn)
PART 9. North America Vaccines market Analysis - By Patient type
9.1 Overview
9.2 NORTH AMERICA Vaccines MARKET, BY patient type, 2018 & 2027 (%)
9.3 North America Vaccines market Revenue And Forecasts to 2027, By patient type (US$ Mn)
9.4 North America pediatric Market
9.4.1 Overview
9.4.2 North America Pediatric Market Revenue and Forecast to 2027 (US$ Mn)
9.5 North America adults Market
9.5.1 Overview
9.5.2 North America Adults Market Revenue and Forecast to 2027 (US$ Mn)
PART 10.North America Vaccines market Revenue and Forecasts to 2027
10.1 Overview
10.1.1 North America Vaccines Market Revenue And Forecasts to 2027 (US$ Mn)
10.1.2 North America Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.3 North America Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.4 North America Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.5 North America Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.6 North America Vaccines Market Revenue And Forecasts to 2027, By Country (%)
10.1.7 US Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8 US Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 US Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.8.2 US Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.8.3 US Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.8.4 US Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.9 Canada Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10 Canada Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.1Canada Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.10.2Canada Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.10.3Canada Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.10.4.. Canada Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.11 Mexico Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12 Mexico Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12.1Mexico Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.12.2 Mexico Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.12.3Mexico Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.12.4Mexico Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
PART 11.Vaccines Market -Industry Landscape
11.1 Overview
11.2 Comparative Company Analysis
11.3 Growth Strategies done by the companies in the Market, (%)
11.4 Organic Developments
11.4.1 Overview
11.5 Inorganic developments
11.5.1 Overview
PART 12.Vaccines Market-Key company profiles
12.1 PFIZER INC.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GlaxoSmithKline plc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck & Co., Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sanofi
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Information
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Johnson & Johnson Services, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Panacea Biotec Limited
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Information
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Astellas Pharma Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 Swot Analysis
12.7.6 Key Developments
12.8 NOVAVAX, INC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Information
12.8.4 Product Pipeline
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 VBI Vaccines Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Information
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BAVARIAN NORDIC
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Information
12.10.4 Product Pipeline
12.10.5 SWOT Analysis
12.10.6 Key Developments
PART 13.Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
LIST OF TABLES
TABLE 1. North America Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 2. North America Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 3. North America vaccines market Revenue And Forecasts to 2027, By route of administration (US$ Mn)
TABLE 4. North America vaccines market Revenue And Forecasts to 2027, By patient type (US$ Mn)
TABLE 5. North America Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 6. North America Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 7. North America Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 8. North America Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
TABLE 9. US Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 10. US Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 11. US Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 12. US Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
TABLE 13. CANADA Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 14. CANADA Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 15. CANADA Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 16. CANADA Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
TABLE 17. MEXICO Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 18. MEXICO Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 19. MEXICO Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 20. MEXICO Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
TABLE 21. Organic Developments Done By Companies
TABLE 22. Inorganic developments done by Companies
TABLE 23. Glossary of Terms, Vaccines market
LIST OF TABLES
FIGURE 1. US Vaccines market, Revenue (US$ Mn), By COuntry 2018 & 2027
FIGURE 2. north America Vaccines Market By Type, Market Share (%), 2018
FIGURE 3. north America vaccines Market By Disease indication, Market Share (%), 2018
FIGURE 4. North America Vaccines Market By route of Administration, Market Share (%), 2018
FIGURE 5. North America Vaccines Market By Patient Type, Market Share (%), 2018
FIGURE 6. Vaccines market Segmentation
FIGURE 7. North America PEST Analysis
FIGURE 8. Vaccines market impact analysis of drivers & Restraints
FIGURE 9. North America Vaccines market - Revenue Forecasts and Analysis - 2018- 2027
FIGURE 10. North America vaccines market, By Technology, 2018 & 2027 (%)
FIGURE 11. North America recombinant vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 12. North America conjugate vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 13. North America live attenuated vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 14. North America inactivated vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 15. North America toxoid vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 16. North America vaccines market By disease indication, 2017 & 2025 (%)
FIGURE 17. North America DTP (diphtheria, tetanus, and pertussis) Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. North America influenza Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. North America hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 20. North America Other Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 21. North America vaccines market By route of administration, 2018 & 2027 (%)
FIGURE 22. North America oral Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 23. North America injectable Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 24. North America other routes of administration Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 25. North America vaccines market By patient type, 2018 & 2027 (%)
FIGURE 26. North America pediatric Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 27. North America adults Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 28. North America Vaccines market revenue Overview, by Country (2017) (us $ mn)
FIGURE 29. North America Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 30. North America Vaccines market Revenue And Forecasts to 2027, By Country (%)
FIGURE 31. US Vaccines market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 32. Canada Vaccines market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 33. Mexico Vaccines market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 34. Comparative Company Analysis
FIGURE 35. Growth Strategies done by the companies in the Market, (%)
The List of Companies - North America Vaccines Market
- PFIZER INC
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Sanofi
- Johnson & Johnson Services, Inc
- Panacea Biotec Limited
- Astellas Pharma Inc.
- NOVAVAX, INC.
- VBI Vaccines Inc
- Bavarian Nordic.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Vaccines Market
Mar 2019
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2019
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2019
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2019
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2019
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2019
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Mar 2019
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Mar 2019
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)